Budget 2026 Winners & Losers

Finance Minister Nirmala Sitharaman presented India’s Union Budget on 1st February, 2026, with a focus on striking the right balance between ‘Viksit Bharat’ and fiscal discipline. The record Rs 12.2 lakh crore CapEx outlay was seen as an indication of infrastructure spending. However, it was a Black Sunday for the market as Securities Transaction Tax (STT) on derivatives was hiked.

Key highlights & policy shifts

The budget had focused on three Kartavyas, that is economic growth, fulfilling aspirations, and inclusive growth.

• CapEx Momentum: Public capital expenditure has risen to ₹12.2 lakh crore from ₹11.2 lakh crore. Emphasis has been placed on seven high-speed rail corridors and Tier II and III cities.
• The F&O "Course Correction": As a step to curb retail speculation, the STT on Futures has more than doubled to 0.05% from 0.02%. The STT on Options, which comprises premium and exercise, has risen to 0.15%.
• Taxation & Buybacks: Some relief can be drawn from the fact that there has been no change in personal income tax rates and capital gains tax rates. Most importantly, the taxation of buyback proceeds has been introduced as capital gains for shareholders rather than dividend income.
• Fiscal Prudence: The fiscal deficit target has been lowered to 4.3% of GDP for FY27 from 4.4%.

Market reaction: The ‘Knee-Jerk’ correction

• Sensex & Nifty: The Sensex lost as much as 1,800-2,000 points, i.e., 2%. The Nifty slipped below 25,000 before trimming some of its losses. 
• Increased Brokerage: Stocks like Angel One fell by as much as 11.84% as investors were concerned about an ‘enormous cut in trading volumes due to high brokerage.’ 
• Recovery: By next Monday, there were signs of value buying in CapEx-intensive blue chips like Larsen & Toubro and HDFC Bank.

Winners vs. Losers

Smart money moves for 2026

• Capex: The focus should now shift to infrastructure and manufacturing-linked mutual fund investments. The Railway sector (RVNL, IRFC) and the Electronics sector (Dixon, Kaynes) are still strong areas.
• Pivot Pharma: The introduction of the Biopharma SHAKTI initiative makes Pharma players such as Biocon and Dr Reddy’s strong investment options.
• NRI Inflow: The doubling of investment limits (10% of each stock) for NRIs is expected to attract stable, non-speculative NRI investment.
• Strategic Discipline: With the New Income Tax Act 2025 coming into effect from April 2026, the focus should shift to ‘Discover in India’ value rather than derivatives.

Conclusion

The Union Budget 2026 is a decisive moment in India's economic journey. By focusing on fiscal discipline and massive CapEx spending while at the same time calming down the overheated F&O market, the Government is signalling a paradigmatic shift: The era of 'easy gains' through high-frequency trading is being replaced by a new mantra of 'long-term value creation.'

Although the initial stock market reaction was a knee-jerk reaction, the underlying fundamentals—bolstered by a massive ₹12.2 lakh crore push to Infra spending and a bold SHAKTI initiative in the Biopharma space—are indicative of a more evolved and stable growth curve. For the Smart Money, the focus is no longer on daily market volatility but on aligning their portfolio with the 'pillars of Viksit Bharat.'